Airway Stent/Lung Stent Market By Product Type (Tracheal Stents, Bronchial Stents, Laryngeal Stents, Tracheobronchial Stents); By Material (Metal Stents (Nitinol, Stainless Steel), Silicone Stents, Hybrid Stents, Others); By Device Type (Self-Expandable Stents, Balloon-Expandable Stents); By End Use / Application (Hospitals, Ambulatory Surgery Centers); By Region – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032
The Airway Stent / Lung Stent Market is projected to grow from USD 91.45 million in 2025 to an estimated USD 151.82 million by 2032, with a compound annual growth rate (CAGR) of 7.5% from 2025 to 2032.
EPORT ATTRIBUTE
DETAILS
Historical Period
2020-2023
Base Year
2024
Forecast Period
2025-2032
Airway Stent/Lung Stent Market Size 2025
USD 91.45 million
Airway Stent/Lung Stent Market, CAGR
7.5%
Airway Stent/Lung Stent Market Size 2032
USD 151.82 million
Strong market drivers include rising incidence of airway obstruction disorders and increased use of interventional pulmonology techniques for both malignant and benign conditions. Clinicians prefer minimally invasive approaches that reduce recovery time and support rapid airflow restoration. Manufacturers introduce hybrid materials, improved coatings, and device designs that lower migration risk and improve durability. Hospitals expand bronchoscopy units to handle complex cases, and growing clinical evidence strengthens physician confidence, encouraging wider adoption across global healthcare systems.
Regional growth patterns show North America leading due to advanced healthcare infrastructure, strong procedural expertise, and widespread access to modern airway stent technologies. Europe follows with steady adoption supported by improved pulmonology training and rising chronic respiratory disease cases. Asia Pacific emerges as the fastest-expanding region due to increasing investment in tertiary care hospitals and broader awareness of minimally invasive airway treatments. Other regions gain traction as healthcare modernization accelerates, expanding clinical access to structured airway management.
Airway Stent/Lung Stent Market Insights:
The Airway Stent / Lung Stent Market is set to grow from USD 91.45 million in 2025 to USD 151.82 million by 2032, driven by a strong 7.5% CAGR supported by rising adoption of minimally invasive airway stabilization.
Market drivers include higher incidence of malignant and benign obstructions, expanding bronchoscopy capabilities, and strong clinical preference for advanced stent materials that improve airway patency.
Key restraints involve migration risks, regulatory complexity, limited standardization, and the need for skilled pulmonology teams to ensure accurate placement and long-term safety.
North America leads due to superior infrastructure and high procedure volumes, while Europe maintains steady growth supported by structured respiratory care programs.
Asia Pacific emerges as the fastest-growing region due to rising investment in tertiary hospitals, improved pulmonology access, and expanding awareness of minimally invasive airway interventions.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
Rising Prevalence of Airway Obstruction Disorders and Higher Need for Interventional Pulmonology Procedures
A steady rise in chronic airway diseases increases demand for advanced stent solutions. Patients present with complex obstructions that require structured support to restore airflow. Clinics adopt minimally invasive procedures to reduce recovery time. Interventional pulmonology teams expand their use of silicone, metallic, and hybrid stents. New clinical guidelines encourage timely stent placement to stabilize compromised airways. Hospitals upgrade bronchoscopy units to handle diverse patient needs. The Airway Stent / Lung Stent Market gains traction through wider clinical acceptance. Growing awareness among patients encourages faster diagnosis and timely treatment decisions.
Growing Preference for Minimally Invasive Airway Stabilization and Reduced Surgical Burden
Healthcare providers prefer techniques that lower procedural risk and shorten hospital stays. Stent placement offers a direct method to reopen obstructed passages. Doctors rely on improved materials that support flexibility and strength. Patients benefit from less trauma and shorter recovery periods. It helps reduce repeat interventions in many high-risk cases. Pulmonologists report rising demand for bronchoscopy-based stenting in emergency care. The Airway Stent / Lung Stent Market secures growth with strong adoption in critical settings. Advancements in device design support higher use across varied disease profiles.
Technological Advancements in Stent Materials, Customization, and Bronchoscopic Delivery Systems
Device makers invest in stronger alloys, improved polymers, and tailored shapes. New delivery systems support precise placement under challenging conditions. It enhances operator confidence during complex airway reconstruction. Computer models help refine sizing for difficult anatomies. Custom solutions reduce migration risk and improve long-term outcomes. Hospitals adopt advanced imaging tools to support accurate deployment. The Airway Stent / Lung Stent Market strengthens through innovation that improves safety and reliability. Production teams also test coatings that reduce infection risk and enhance durability.
For instance, Micro-Tech (Nanjing) Co., Ltd. manufactures globally distributed nitinol airway stents and holds multiple FDA 510(k) clearances across its minimally invasive product portfolio, demonstrating validated manufacturing quality and regulatory-compliant device development.
Expanding Applications in Malignant and Benign Airway Diseases with Broader Clinical Evidence
Oncologists rely on airway stents to manage tumor-related obstruction. Patients with benign strictures also require durable solutions for sustained relief. Clinical trials report improved breathing outcomes following structured stenting. It increases physician confidence and drives inclusion in treatment plans. Hospitals see higher referrals for airway reconstruction services. Multidisciplinary teams collaborate to optimize placement strategies. The Airway Stent / Lung Stent Market benefits from broader use across complex lung conditions. Growth stems from expanded clinical training and rising demand for standardized protocols.
For instance, the FDA granted De Novo clearance in October 2024, for Peytant Solutions’ AMStent Tracheobronchial Covered Stent System, authorizing it specifically for the treatment of tracheobronchial strictures caused by malignant neoplasms in adult patients, and recognizing it as the first airway stent to use a decellularized human amniotic membrane (DCAM) covering.
Airway Stent/Lung Stent Market Trends
Increasing Use of 3D-Printed and Patient-Specific Stent Designs for Complex Anatomical Cases
Clinics now explore 3D-printed stents for rare airway deformities. Tailored geometry helps improve fit and stability in difficult cases. It strengthens outcomes by reducing pressure points and migration events. Engineers refine polymers that support long-term tolerance. Surgeons request custom models when conventional designs fail. Digital planning tools improve placement accuracy before procedures. The Airway Stent / Lung Stent Market evolves toward a personalized treatment approach. Hospitals invest in rapid-prototype workflows to shorten preparation time.
For instance, VisionAir Solutions reported developing more than 600 patient-specific, AI-assisted 3D-printed airway stents, supported by its proprietary design platform and collaborations with major U.S. medical centers.
Growing Adoption of Bioabsorbable Stents that Support Temporary Airway Relief Without Removal Needs
Research teams progress toward dissolvable implants that reduce follow-up procedures. Bioabsorbable solutions support healing without permanent placement. It lowers complications linked to long-term device retention. Trials explore controlled-degradation materials for predictable performance. Doctors monitor patient outcomes to confirm safety in varied conditions. These devices appeal to cases requiring short-term airway support. The Airway Stent / Lung Stent Market shifts toward solutions that reduce patient burden. Manufacturers refine degradation rates for more precise therapeutic windows.
Integration of Advanced Imaging and Navigation Tools to Improve Placement Accuracy and Reduce Complications
Hospitals deploy navigation software for real-time airway mapping. Enhanced imaging reduces uncertainty during bronchoscopy. It supports smoother delivery of rigid or flexible stents. Doctors value guided pathways for complex tumors or strictures. Navigation helps reduce misplacement events and lowers post-procedure adjustments. Clinics expand training to handle these digital tools. The Airway Stent / Lung Stent Market grows through alignment with next-generation visualization systems. Providers prioritize platforms that improve safety and procedural speed.
Rising Focus on Hybrid Stents with Improved Flexibility, Anti-Migration Features, and Stronger Radial Force
Manufacturers test hybrid structures that combine silicone and metal performance. These designs help balance comfort with stronger support. It reduces risk of collapse in high-compression zones. Anti-migration patterns keep the stent stable under airflow pressure. Clinics require devices that resist mucus buildup and maintain patency longer. Engineers refine coatings for smoother inner surfaces. The Airway Stent / Lung Stent Market moves toward multifunction stents that support varied disease needs. Hospitals expand inventories to match complex treatment demands.
For instance, Taewoong Medical’s Niti-S™ Conical Stent and other hybrid configurations are widely documented in pulmonary procedure registries and supported by CE-mark certifications across multiple international markets.
Regulatory Constraints, Limited Standardization, and Rising Concern Over Device-Related Complications
Regulators enforce strict review processes that extend approval timelines. Manufacturers face barriers when evidence varies across patient groups. It creates delays that impact product launches in major regions. Hospitals report concerns linked to migration, infection, or granulation tissue. Doctors require clearer guidelines to support consistent placement decisions. Variability across stent types complicates training and procurement efforts. The Airway Stent / Lung Stent Market must navigate safety expectations while expanding innovation. Companies invest in risk-reduction studies to strengthen clinical acceptance.
High Cost Burden, Limited Skilled Workforce, and Uneven Access to Advanced Pulmonology Infrastructure
Treatment expenses increase due to specialized equipment and procedural needs. Patients in low-resource regions struggle to secure advanced care. It restricts adoption where reimbursement remains weak. Hospitals need trained teams to perform challenging stent placements. A shortage of skilled pulmonologists reduces procedure volumes in many regions. Infrastructure gaps limit access to high-quality bronchoscopy systems. The Airway Stent / Lung Stent Market faces pressure to balance affordability with performance. Providers push for training programs to close capability gaps.
Airway Stent/Lung Stent Market Opportunities
Expansion of Customizable Stent Platforms, AI-Based Planning Tools, and Rapid Design Technologies
Custom platforms support better alignment with unique airway structures. Engineers partner with clinicians to refine patient-specific profiles. It encourages wider adoption of tailored treatment pathways. AI planning tools suggest precise stent sizes using imaging data. Hospitals value predictive insights that support smoother procedures. Manufacturers gain growth potential through modular design models. The Airway Stent / Lung Stent Market enters a phase that rewards customization and precision. Clinics upgrade workflows to integrate automated planning steps.
Growing Investment in Pulmonology Care, Emerging-Region Infrastructure, and Multidisciplinary Airway Centers
Governments fund advanced respiratory care units across developing regions. New centers focus on minimally invasive lung procedures. It drives volume growth through improved access to stent services. Training partnerships strengthen clinical expertise in complex airway management. Hospitals adopt standardized pathways that reduce complication rates. Investors support networks that expand high-quality bronchoscopic care. The Airway Stent / Lung Stent Market benefits from strong demand in rapidly modernizing healthcare systems. Upgraded infrastructure supports wider adoption across diverse patient populations.
Tracheal, bronchial, laryngeal, and tracheobronchial stents hold distinct roles across routine and complex airway disorders. Tracheal stents support patients with central airway collapse and severe obstruction linked to trauma or tumors. Bronchial stents serve segmental pathways where targeted stabilization helps restore airflow. Laryngeal stents help surgeons manage post-operative swelling and structural deformities. Tracheobronchial stents help address extended disease spread across multiple airway zones. Doctors choose each type based on pathology, stability needs, and long-term tolerance. Strong demand for precision devices strengthens the Airway Stent / Lung Stent Market through expanded treatment planning. It creates opportunities for specialized shapes and designs that improve patient outcomes.
By Material
Metal, silicone, hybrid, and other materials influence durability, comfort, and performance across diverse airway conditions. Metal stents offer high radial strength for tight obstructions and complex malignant cases. Silicone stents help reduce tissue irritation and support easier removal during follow-up care. Hybrid stents balance flexibility with structural integrity to improve placement stability. Other emerging materials explore coatings that lower infection risk and mucus buildup. Doctors evaluate each option based on patient tolerance and disease severity. The Airway Stent / Lung Stent Market gains momentum through material advances that boost reliability. It supports broader clinical adoption across both short-term and long-term therapy needs.
For instance, Novatech SA’s Dumon™ silicone stent has been commercially used for more than 30 years, with thousands of documented clinical implantations across international pulmonology centers.
By Device Type
Self-expandable and balloon-expandable stents address different procedural needs within interventional pulmonology. Self-expandable designs adjust to airway contours and help maintain continuous pressure on obstructed tissue. These devices support smoother placement in tight or irregular passages. Balloon-expandable options offer controlled expansion during deployment, which benefits anatomies requiring exact sizing. Doctors weigh ease of placement, reposition capability, and long-term patency before selecting a device. Product diversity strengthens the Airway Stent / Lung Stent Market by supporting case-specific decision pathways. It encourages device makers to refine expansion mechanisms that elevate procedural accuracy.
For instance, Medtronic’s superDimension™ Navigation System, which supports accurate deployment of self-expandable devices, has been utilized in more than 300,000 electromagnetic navigation bronchoscopy procedures globally.
By End Use / Application
Hospitals and ambulatory surgery centers rely on structured airway interventions to manage critical obstruction cases. Hospitals handle complex emergencies, malignant obstructions, and high-risk patients who need advanced imaging and bronchoscopy support. These settings manage multidisciplinary workflows that require dedicated pulmonology teams. Ambulatory surgery centers focus on stable patients needing short-procedure interventions with fast discharge. Their efficiency strengthens access to minimally invasive care across urban regions. Decision makers assess throughput, equipment availability, and staff expertise when selecting stent platforms. The Airway Stent / Lung Stent Market expands through rising procedure volumes across both facility types. It enables broader adoption of standardized care models that enhance patient recovery.
Segmentation:
By Product Type
Tracheal Stents
Bronchial Stents
Laryngeal Stents
Tracheobronchial Stents
By Material
Metal Stents (Nitinol, Stainless Steel)
Silicone Stents
Hybrid Stents
Others
By Device Type
Self-Expandable Stents
Balloon-Expandable Stents
By End Use / Application
Hospitals
Ambulatory Surgery Centers
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
South-east Asia
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of the Middle East and Africa
Regional Analysis:
North America holds the leading share of the global landscape with roughly 38% of the market. Strong pulmonology infrastructure and high adoption of minimally invasive procedures support this position. Hospitals invest in advanced bronchoscopy suites and structured airway programs. It drives higher use of tracheal and bronchial stents in both malignant and benign conditions. Clinical guidelines reinforce early intervention for complex airway diseases. The Airway Stent / Lung Stent Market gains steady momentum from strong reimbursement pathways and robust product availability.
Europe accounts for close to 30% of the global share, supported by rising adoption of hybrid stents and expanded use of navigation-assisted bronchoscopy. Leading countries introduce enhanced respiratory care protocols that encourage structured airway stabilization. Healthcare systems focus on precision-based treatment and improved training for interventional pulmonology teams. It raises demand for self-expandable and silicone stents across major clinics. Hospitals align procurement with quality standards that support long-term airway management. The region strengthens the Airway Stent / Lung Stent Market through rising chronic disease incidence and aging populations.
Asia Pacific holds nearly 22% of the market and records the fastest expansion due to large patient populations with obstructive airway disorders. Investments in tertiary care hospitals and cancer centers improve access to advanced procedures. Regional demand increases with rising awareness of minimally invasive therapy. It encourages health systems to introduce new pulmonology units and adopt updated bronchoscopy platforms. Training programs expand as clinicians integrate modern stent technologies into routine practice. The Airway Stent / Lung Stent Market gains traction through rapid healthcare modernization across major economies.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
The competitive landscape includes global device companies, specialized stent manufacturers, and regional firms focused on airway reconstruction products. Leaders compete through design precision, material innovation, and strong clinical support programs. It raises expectations for durability, flexibility, and safe deployment across varied airway anatomies. Companies expand portfolios with hybrid stents and enhanced anti-migration features to improve long-term outcomes. Mid-sized manufacturers grow by offering cost-effective systems for hospitals in emerging regions. The Airway Stent / Lung Stent Market remains dynamic due to continuous design upgrades, strategic distribution partnerships, and increased focus on personalized airway solutions. Firms strengthen their position through regulatory compliance, clinician training, and broader geographic reach.
Recent Developments:
In February 2025, Micro-Tech (Nanjing) Co., Ltd. completed the strategic acquisition of a 51% stake in Creo Medical S.L.U. (CME), enhancing its global expansion in minimally invasive medical technologies including pulmonology products like airway stents.
In October 2024, Peytant Solutions received FDA de novo clearance for its AMStent system, a novel airway stent featuring a metal frame covered with human amnion tissue to manage tracheobronchial obstructions from malignant tumors marking a significant advancement in minimally invasive palliative care for respiratory patients.
In July 2024, VisionAir Solutions announced a strategic partnership with Lazzaro Medical to expand its patient-specific 3D-printed airway stents, building on over 600 custom stents developed using AI software. supports upcoming launches of off-the-shelf patient-matched stents expected late 2024 to early 2025.
Report Coverage:
The research report offers an in-depth analysis based on Product Type, Material, Device Type, End Use / Application and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook:
Growing adoption of minimally invasive airway stabilization will strengthen clinical demand across high-volume centers.
Rising cases of malignant obstruction will expand placement needs for advanced stent platforms.
Hybrid stents with stronger flexibility and low migration risk will gain wider acceptance among pulmonologists.
Broader integration of navigation tools and imaging support will improve deployment accuracy in complex pathways.
Custom and 3D-printed designs will support tailored care for patients with unusual airway geometries.
Hospitals will expand bronchoscopy units to meet increased patient load for airway reconstruction procedures.
Emerging markets will record faster uptake as healthcare infrastructure improves across major regions.
Material innovation will push manufacturers to create safer, more durable devices for varied disease severity.
Training programs for interventional pulmonology will raise procedure accuracy and reduce complication rates.
Strategic partnerships will help companies expand distribution and strengthen the Airway Stent / Lung Stent Market footprint globally.
1. Introduction
1.1. Report Description
1.2. Purpose of the Report
1.3. USP & Key Offerings
1.4. Key Benefits for Stakeholders
1.5. Target Audience
1.6. Report Scope
1.7. Regional Scope
2. Scope and Methodology
2.1. Objectives of the Study
2.2. Stakeholders
2.3. Data Sources
2.3.1. Primary Sources
2.3.2. Secondary Sources
2.4. Market Estimation
2.4.1. Bottom-Up Approach
2.4.2. Top-Down Approach
2.5. Forecasting Methodology
10.1. Overview
10.2. Bargaining Power of Buyers
10.3. Bargaining Power of Suppliers
10.4. Degree of Competition
10.5. Threat of New Entrants
10.6. Threat of Substitutes
11. Price Analysis
12. Competitive Landscape
12.1. Market Structure
12.2. Key Players
12.3. Company Profiles
12.3.1. Company 1
• Company Overview
• Product Portfolio
• Financials
• SWOT Analysis
12.3.2. Company 2
…
12.3.10. Company 10
13. Research Methodology
Request A Free Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Questions
What is the current market size for the Airway Stent / Lung Stent Market, and what is its projected size in 2032?
The Airway Stent / Lung Stent Market stands at USD 91.45 million, supported by rising demand for minimally invasive airway care. It is projected to reach USD 151.82 million by 2032, driven by broader adoption of advanced stent technologies.
At what Compound Annual Growth Rate is the Airway Stent / Lung Stent Market projected to grow between 2025 and 2032?
The Airway Stent / Lung Stent Market is expected to grow at a 7.5% CAGR during the forecast period, supported by material innovation, improved procedure capabilities, and stronger clinical preference for airway stabilization.
Which Airway Stent / Lung Stent Market segment held the largest share in 2025?
The Airway Stent / Lung Stent Market recorded its highest share in the tracheal and bronchial stent segment, supported by high treatment volume and strong demand across interventional pulmonology units.
What are the primary factors fueling the growth of the Airway Stent / Lung Stent Market?
Growth in the Airway Stent / Lung Stent Market is driven by rising airway obstruction cases, expanding bronchoscopy capabilities, stronger focus on minimally invasive therapy, and advanced stent materials that improve patient outcomes.
Who are the leading companies in the Airway Stent / Lung Stent Market?
Leading players in the Airway Stent / Lung Stent Market include Boston Scientific, Taewoong Medical, Cook Medical, Micro-Tech, Merit Medical, Novatech SA, and Endo-Flex, each contributing to product innovation and clinical adoption.
Which region commanded the largest share of the Airway Stent / Lung Stent Market in 2025?
North America held the largest share of the Airway Stent / Lung Stent Market in 2025, supported by strong pulmonology infrastructure, high procedure rates, and broad access to advanced airway stent technologies.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
The commercial aquaculture vaccines market was valued at USD 471 million in 2024 and is projected to reach USD 845.93 million by 2032, expanding at a compound annual growth rate (CAGR) of 7.6% during the forecast period.
The global bone growth stimulator market was valued at USD 1,890 million in 2024 and is projected to reach USD 3,058.14 million by 2032, expanding at a compound annual growth rate (CAGR) of 6.2% during the forecast period.
The global antioxidants market was valued at USD 4,095.8 million in 2024 and is anticipated to reach USD 6,657.29 million by 2032, expanding at a CAGR of 6.26% during the forecast period.
US Pharma R&D Outsourcing Market size was valued at USD 30,916.90 Million in 2024 and is anticipated to reach USD 67,782.11 Million by 2032, at a CAGR of 10.31% during the forecast period.
UAE Over-the-Counter (OTC) Pharmaceuticals Market size was valued at USD 2,913 million in 2024 and is anticipated to reach USD 4,110.63 million by 2032, at a CAGR of 4.4% during the forecast period.
The Prostatic Catheter Market size was valued at USD 199 million in 2024 and is anticipated to reach USD 309.44 million by 2032, at a CAGR of 5.7% during the forecast period.
The Rapid Microbiology Tests Market size was valued at USD 6,178 million in 2024 and is anticipated to reach USD 10496.15 million by 2032, at a CAGR of 6.85 % during the forecast period.
The Reversible Airway Diseases Treatment Market size was valued at USD 85,518 million in 2024 and is anticipated to reach USD 143671.9 million by 2032, at a CAGR of 6.7 % during the forecast period.
The RNA Targeting Small Molecule Drug Discovery Market size was valued at USD 1,723 million in 2024 and is anticipated to reach USD 8852.98 million by 2032, at a CAGR of 22.7 % during the forecast period.
The Rare Disease Clinical Trials Market size was valued at USD 12,949 million in 2024 and is anticipated to reach USD 21592.72 million by 2032, at a CAGR of 6.6 % during the forecast period.
The Rare Disease Genetic Testing Market size was valued at USD 1,197 million in 2024 and is anticipated to reach USD 3703.24 million by 2032, at a CAGR of 15.16 % during the forecast period.
The RAS Mutation Detection Kit Market size was valued at USD 107 million in 2024 and is anticipated to reach USD 188.53 million by 2032, at a CAGR of 7.4 % during the forecast period.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$3999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$4999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
